Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2010, Article ID 136502, 11 pages
http://dx.doi.org/10.1155/2010/136502
Research Article

Body Weight Control by a High-Carbohydrate/Low-Fat Diet Slows the Progression of Diabetic Kidney Damage in an Obese, Hypertensive, Type 2 Diabetic Rat Model

1Research Division, Chugai Pharmaceutical Co., LTD., Shizuoka 412-8513, Japan
2Institute of Medical Sciences, Tokai University, Kanagawa 259-1193, Japan
3Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo 113-8655, Japan
4Center for Translational and Advanced Research, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan
5Department of Nephrology, Hypertension and Endocrinology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan
6Service de Nephrologie, Universite Catholique de Louvain, 1200 Brussels, Belgium

Received 11 June 2009; Revised 7 October 2009; Accepted 16 November 2009

Academic Editor: Terry Huang

Copyright © 2010 Shuichi Ohtomo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Sarafidis and L. M. Ruilope, “Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications,” American Journal of Nephrology, vol. 26, no. 3, pp. 232–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Trovati and F. Cavalot, “Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal diseas,” Journal of the American Society of Nephrology, vol. 15, supplement 1, pp. S12–S20, 2004. View at Google Scholar · View at Scopus
  3. P. A. Sarafidis and G. L. Bakris, “Protection of the kidney by thiazolidinediones: an assessment from bench to bedside,” Kidney International, vol. 70, no. 7, pp. 1223–1233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Remuzzi, M. Macia, and P. Ruggenenti, “Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study,” Journal of the American Society of Nephrology, vol. 17, supplement 2, pp. S90–S97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Fioretto, M. Bruseghin, I. Berto, P. Gallina, E. Manzato, and M. Mussap, “Renal protection in diabetes: role of glycemic control,” Journal of the American Society of Nephrology, vol. 17, supplement 2, pp. S86–S89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Locatelli, P. Pozzoni, and L. Del Vecchio, “Renal manifestations in the metabolic syndrome,” Journal of the American Society of Nephrology, vol. 17, supplement 2, pp. S81–S85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Izzedine, M. Coupaye, I. Reach, and G. Deray, “Gastric bypass and resolution of proteinuria in an obese diabetic patient,” Diabetic Medicine, vol. 22, no. 12, pp. 1761–1762, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Saiki, D. Nagayama, M. Ohhira et al., “Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy,” International Journal of Obesity, vol. 29, no. 9, pp. 1115–1120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Morales, M. A. Valero, M. León, E. Hernández, and M. Praga, “Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies,” American Journal of Kidney Diseases, vol. 41, no. 2, pp. 319–327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Praga, “Therapeutic measures in proteinuric nephropathy,” Kidney International. Supplement, no. 99, pp. S137–S141, 2005. View at Google Scholar · View at Scopus
  11. M. Nangaku, T. Miyata, T. Sada et al., “Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1212–1222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ohtomo, Y. Izuhara, S. Takizawa et al., “Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model,” Kidney International, vol. 72, no. 12, pp. 1512–1519, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Poppitt, G. F. Keogh, A. M. Prentice et al., “Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome,” American Journal of Clinical Nutrition, vol. 75, no. 1, pp. 11–20, 2002. View at Google Scholar · View at Scopus
  14. B. Bahadori, B. Yazdani-Biuki, P. Krippl, H. Brath, E. Uitz, and T. C. Wascher, “Low-fat, high-carbohydrate (low-glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study,” Diabetes, Obesity and Metabolism, vol. 7, no. 3, pp. 290–293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Ingelfinger, F. Jung, D. Diamant et al., “Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback,” American Journal of Physiology, vol. 276, no. 2, pp. F218–F227, 1999. View at Google Scholar · View at Scopus
  16. B. E. Wisse, “The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity,” Journal of the American Society of Nephrology, vol. 15, no. 11, pp. 2792–2800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Wiecek, M. Adamczak, and J. Chudek, “Adiponectin—an adipokine with unique metabolic properties,” Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 981–988, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. F. P. Schena and L. Gesualdo, “Pathogenetic mechanisms of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 16, no. 3, supplement 1, pp. S30–S33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. N. Ziyadeh, “Mediators of diabetic renal disease: the case for TGF-β as the major mediator,” Journal of the American Society of Nephrology, vol. 15, supplement 1, pp. S55–S57, 2004. View at Google Scholar · View at Scopus
  21. I. Z. A. Pawluczyk and K. P. G. Harris, “Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells,” Kidney International, vol. 54, no. 1, pp. 62–70, 1998. View at Google Scholar · View at Scopus
  22. A. O. Phillips, N. Topley, R. Steadman, K. Morrisey, and J. D. Williams, “Induction of TGF-β1 synthesis in D-glucose primed human proximal tubular cells by IL-1β and TNFα,” Kidney International, vol. 50, no. 5, pp. 1546–1554, 1996. View at Google Scholar · View at Scopus
  23. K. Horie, T. Miyata, K. Maeda et al., “Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 2995–3004, 1997. View at Google Scholar · View at Scopus
  24. D. Suzuki, T. Miyata, N. Saotome et al., “Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions,” Journal of the American Society of Nephrology, vol. 10, no. 4, pp. 822–832, 1999. View at Google Scholar · View at Scopus
  25. J. M. Bohlender, S. Franke, G. Stein, and G. Wolf, “Advanced glycation end products and the kidney,” American Journal of Physiology, vol. 289, no. 4, pp. F645–F659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. B. Lee, M.-R. Yu, Y. Yang, Z. Jiang, and H. Ha, “Reactive oxygen species-regulated signaling pathways in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, supplement 3, pp. S241–S245, 2003. View at Google Scholar · View at Scopus
  27. S. Ohtomo, M. Nangaku, Y. Izuhara, S. Takizawa, C. V. Y. D. Strihou, and T. Miyata, “Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model,” Nephrology Dialysis Transplantation, vol. 23, no. 4, pp. 1166–1172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Nangaku, Y. Izuhara, N. Usuda et al., “In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy,” Nephrology Dialysis Transplantation, vol. 20, no. 12, pp. 2661–2669, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Izuhara, M. Nangaku, R. Inagi et al., “Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering,” Journal of the American Society of Nephrology, vol. 16, no. 12, pp. 3631–3641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yokoi, M. Mukoyama, K. Mori et al., “Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice,” Kidney International, vol. 73, no. 4, pp. 446–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Guha, Z.-G. Xu, D. Tung, L. Lanting, and R. Natarajan, “Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes,” The FASEB Journal, vol. 21, no. 12, pp. 3355–3368, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. B. Lee and H. Ha, “Plasminogen activator inhibitor-1 and diabetic nephropathy,” Nephrology, vol. 10, supplement 2, pp. S11–S13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. F. Navarro, F. J. Milena, C. Mora et al., “Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition,” Kidney International. Supplement, no. 99, pp. S98–S102, 2005. View at Google Scholar · View at Scopus
  34. S. Okada, K. Shikata, M. Matsuda et al., “Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes,” Diabetes, vol. 52, no. 10, pp. 2586–2593, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Ina, H. Kitamura, T. Okeda et al., “Vascular cell adhesion molecule-1 expression in the renal interstitium of diabetic KKAy mice,” Diabetes Research and Clinical Practice, vol. 44, no. 1, pp. 1–8, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Yenicesu, M. I. Yilmaz, K. Caglar et al., “Adiponectin level is reduced and inversely correlated with the degree of proteinuria in type 2 diabetic patients,” Clinical Nephrology, vol. 64, no. 1, pp. 12–19, 2005. View at Google Scholar · View at Scopus
  37. M. I. Yilmaz, A. Sonmez, K. Caglar et al., “Peroxisome proliferator-activated receptor ? (PPAR-?) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria,” Endocrine, vol. 25, no. 3, pp. 207–214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Ohashi, H. Iwatani, S. Kihara et al., “Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 9, pp. 1910–1917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Figarola, S. Scott, S. Loera et al., “Lr-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats,” Diabetologia, vol. 46, no. 8, pp. 1140–1152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. T. P. Degenhardt, N. L. Alderson, D. D. Arrington et al., “Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat,” Kidney International, vol. 61, no. 3, pp. 939–950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Thallas-Bonke, C. Lindschau, B. Rizkalla et al., “Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-a—dependent pathway,” Diabetes, vol. 53, no. 11, pp. 2921–2930, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Kelly, R. E. Gilbert, A. J. Cox, T. Soulis, G. Jerums, and M. E. Cooper, “Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2098–2107, 2001. View at Google Scholar · View at Scopus
  43. H. Ha and H. B. Lee, “Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney,” Nephrology, vol. 10, supplement 2, pp. S7–S10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Schleicher and U. Friess, “Oxidative stress, AGE, and atherosclerosis,” Kidney International. Supplement, no. 106, pp. S17–26, 2007. View at Google Scholar · View at Scopus
  45. M. L. McCormick, D. Gavrila, and N. L. Weintraub, “Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 461–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Jiang, X. X. Wang, P. Scherzer et al., “Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy,” Diabetes, vol. 56, no. 10, pp. 2485–2493, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. H.-J. Gröne, A. Walli, E. Gröne et al., “Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat,” Laboratory Investigation, vol. 60, no. 3, pp. 433–446, 1989. View at Google Scholar · View at Scopus
  48. R. J. Bosma, J. A. Krikken, J. J. Homan van der Heide, P. E. de Jong, and G. J. Navis, “Obesity and renal hemodynamics,” Contributions to Nephrology, vol. 151, pp. 184–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. L. G. Feld, B. Noble, J. E. Springate, M. J. Feldman, and J. B. Van Liew, “Dietary protein restriction and renal injury in the spontaneously hypertensive rat,” American Journal of Physiology, vol. 256, no. 2, pp. F224–F228, 1989. View at Google Scholar · View at Scopus